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Available online 5 November 2013Abstract Understanding gene regulatory networks controlling properties of pluripotent stem cells will facilitate
development of stem cell-based therapies. The transcription factor Foxd3 is critical for maintenance of self-renewal, survival,
and pluripotency in murine embryonic stem cells (ESCs). Using a conditional deletion of Foxd3 followed by gene expression
analyses, we demonstrate that genes required for several developmental processes including embryonic organ development,
epithelium development, and epithelial differentiation were misregulated in the absence of Foxd3. Additionally, we identified
6 novel targets of Foxd3 (Sox4, Safb, Sox15, Fosb, Pmaip1 and Smarcd3). Finally, we present data suggesting that Foxd3
functions upstream of genes required for skeletal muscle development. Together, this work provides further evidence that
Foxd3 is a critical regulator of murine development through the regulation of lineage specific differentiation.
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Open access un
☆ All experiments were carried out at Vanderbilt University
Medical Center.and ethical considerations of using human ESCs (hESCs), one
goal of stem cell biologists is to determine the transcrip-
tional networks controlling stem cell properties in other
models of pluripotent stem cells including murine ESCs and/
or induced pluripotent stem cells (iPSCs). Our lab deter-
mined that the Forkhead transcription factor Foxd3 is
required for self-renewal and potency of ESCs (Liu and
Labosky, 2008). Without Foxd3, several signature stem cell
proteins and their corresponding mRNAs (including Oct4,
Sox2, and Nanog) are maintained at relatively normal levels
suggesting that Foxd3 is not required for their expression.
Despite the maintained expression of these genes, ESCs
lacking Foxd3 lose key stem cell properties. They are no
longer pluripotent; they differentiate into mesendoderm
and trophectoderm lineages under conditions that normally
maintain pluripotency. Additionally, inducible-mutant ESCs
lose self-renewal capacity and undergo aberrant apoptosis
(Liu and Labosky, 2008). While Foxd3 is not one of the “core”der the CC BY-NC-ND license.
234 J.L. Plank et al.transcription factors sufficient for reprogramming somatic
cells into iPSCs (Yu et al., 2007), it is indispensable
for generating iPSCs; mouse embryonic fibroblasts lacking
Foxd3 cannot be reprogrammed into pluripotent stem cells
(Suflita, Labosky, and Ess, 2013 unpublished data). Together,
these data demonstrate that Foxd3 functions downstream of,
or in a pathway parallel to, other stem cell factors and is
required for self-renewal and pluripotency of ESCs.
Because Foxd3 regulates stem cell properties in multiple
lineages (Liu and Labosky, 2008; Hanna et al., 2002; Mundell et
al., 2012; Mundell and Labosky, 2011; Teng et al., 2008;
Tompers et al., 2005), Foxd3 target genes must regulate
self-renewal, pluripotency, and/or survival of stem cells.
Currently, only two direct targets of Foxd3 have been identified
(Alb1 and the λ5-preB locus) (Liber et al., 2010; Xu et al., 2007).
Therefore, we sought to identify additional targets of Foxd3.
Using microarrays, qRT-PCR, and ChIP assays, we identified 6
novel targets of Foxd3: Sox4, Safb, Sox15, Fosb, Pmaip1 and
Smarcd3. Additionally, we present data that Foxd3 functions
upstream of genes required for skeletal muscle differentiation.
Materials and methods
Cell culture
Foxd3 inducible-mutant ESC lines were previously character-
ized (Liu and Labosky, 2008). The cells weremaintained using
standard procedures (Nagy, 2003). To generate EBs, ESCs
were dissociated into a single cell suspension, preplated to
deplete feeder cells, and diluted to a final concentration of
20,000 cells/mL in ESC medium lacking LIF. Tamoxifen (TM,
2 μM) was added to mutant cultures, and 400 cells (20 μL)
were placed on the underside of a culture dish lid to form
hanging drops (Samuelson and Metzger, 2006). After 3 days in
culture, EBs were transferred to a 10 cm dish to be cultured
for an additional 2 days. EBs were harvested for RNA analysis
on Day 3. and Day 5.
Immunocytochemistry
Immunocytochemistry to detect Foxd3 protein was performed
following standard techniques (Liu and Labosky, 2008) with
the Foxd3 primary antiserum (Tompers et al., 2005) diluted in
blocking (5% normal donkey serum in PBS) solution (1:1000).
RNA isolation and qRT-PCR
ESCs were harvested, RNA extracted as described (Liu and
Labosky, 2008), and cDNA generated using the GoScript
Reverse Transcription System (Promega). cDNA samples were
amplified in an Applied Biosystems 7900HT Real-Time PCR
system using GoTaq qPCR Master Mix (Promega). Relative gene
expression was calculated as described (Livak and Schmittgen,
2001). Primer sequences are listed in Table S1. Statistical
significancewas determined using a two-tailed Student's t-test.
Microarray analysis
Microarray images were scanned with an Affymetrix high
resolution GenePix 4000B scanner. Raw. CEL files wereuploaded into Partek Genomics Suite version 6.6 (Partek
Incorporated) and processed using Robust Multi-chip Average
(RMA) normalization (Bolstad et al., 2003), and all three
possible individual pairwise comparisons of average group
values were analyzed with one-way ANOVA. Probes that
showed at least 1.5-fold change with a p-value less than 0.05
were considered significantly altered.
Gene functions were determined using NCBI Entrez Gene,
Stanford SOURCE, Aceview, and Pubmed databases. Se-
quences for differential probes not associated with tran-
scripts, based on Affymetrix database annotations, were
retrieved from the Affymetrix NetAffx Analysis Center web
site. Statistical analyses (including corrections for multiple
hypothesis testing) for identification of overrepresented
functional categories and pathways were performed using
Partek Genomics Suite and DAVID (Huang da et al., 2009).
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were per-
formed using established methods (Liber et al., 2010). DNA
was immunoprecipitated, purified, and amplified using qPCR
(as above). The ΔΔCt method was used to calculate
enrichment of Foxd3 at putative binding sites and Ser5-PolII
enrichment at the proximal promoter of target genes. First,
the Ct of the immunoprecipitated sample was normalized to
input DNA for each amplicon (ΔCt). Next, the ΔCt values
obtained from the Foxd3 (Millipore) and Ser5 PolII (Abcam)
immunoprecipitated samples were normalized to the ΔCt of
non-specific IgG (Santa Cruz) immunoprecipitated sample
(ΔΔCt). In the case of PolII ChIP, samples were normalized by
dividing the ΔΔCt value of the TM-treated samples by the
ΔΔCt value of the untreated samples. Primer sequences are
listed in Table S1. Statistical significance was determined
using a Student's t-test comparing the enrichment of
not-treated and TM-treated ESCs.
Results
Foxd3 regulates developmental processes
To characterize the function of Foxd3, we used ESCs carrying
two conditional alleles of Foxd3 with the entire coding
sequence flanked by LoxP sites (Teng et al., 2008). To delete
the locus, the ESCs also carried a ubiquitously expressed Cre
recombinase transgene (Liu and Labosky, 2008). Upon
addition of Tamoxifen (TM), the Foxd3 coding sequence was
deleted. Using qRT-PCR, we determined that Foxd3 mRNA
levels were significantly reduced 12 h after the addition of
TM, and this reduction in Foxd3 mRNA was more pronounced
following 24 h of TM treatment (Fig. 1A). To determine when
Foxd3 protein was diminished, we performed fluorescent
immunocytochemistry. After 12 h of culture with TM, Foxd3
protein was reduced but could still be detected (Figs. 1B–C).
However, 24 h after TM addition, Foxd3 protein was only
rarely detected (Figs. 1D–E), suggesting that Foxd3 protein
persists after loss of Foxd3 mRNA, presumably due to the
half-life of the protein. Therefore, to enable us to detect
gene regulatory differences due to the loss of Foxd3, we
completed our experiments after ESCs were cultured with TM
for at least 24 h.
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Figure 1 Foxd3 protein cannot be detected after 24 h in culture
with Tamoxifen (TM). A. qRT-PCR analysis of Foxd3 mRNA levels
after 12 and 24 h of culture with TM. Relative Foxd3 expression is
decreased in TM-treated ESCs (green) at both time points
compared to untreated controls (gray). Error bars indicate SEM.
***p b 0.001. N = 3 experiments. The expression of Foxd3 in NT
cells is set to 1. B–E. Immunocytochemistry analysis of Foxd3
protein expression (red) after 12 (B–C) and 24 (D–E) hours in
culture in NT (B, D) and TM-treated (C, E) ESCs. Nuclei are
indicated by DAPI (blue).
235Transcriptional targets of Foxd3 in murine ES cellsTo characterize genes misregulated in the absence of
Foxd3, we used Affymetrix Gene/Exon microarrays to
determine which genes were misregulated in the absence
of Foxd3 after 24 h of TM treatment (N = 3 hybridizations of
each group). Statistical analysis of the TM treated versus not
treated cells yielded 423 significantly differentially
expressed probes (Table S2). Hierarchical clustering of
normalized hybridization signals for these 423 probessuccessfully separated the TM-treated from untreated cells
based on gene expression patterns (Fig. 2A), suggesting that
the findings from each experiment were highly reproducible
and gene expression patterns between control cells and
TM-treated cells were distinct.
To further analyze the function of genes misregulated in
the absence of Foxd3, we used functional analysis program,
DAVID, to identify significantly enriched gene ontologies
(Table 1). These data suggested that Foxd3 regulates genes
controlling several developmental processes including
embryonic organ development, epithelium development,
and epithelial differentiation. On a pathway level, Foxd3
regulates components of the Wnt and FGF signaling
pathways (Table 1), specifically Fgf4 and its receptor Fgf2r
(Bellosta et al., 2001). Strikingly, mice lacking β-catenin, a
downstream mediator of canonical Wnt signaling, die at
approximately 6.5 days post coitum (dpc) with disrupted
embryonic tissues and morphologically normal extraembry-
onic tissue (Haegel et al., 1995), and Fgf4 null embryos die
around implantation due to impaired expansion of the
epiblast (Feldman et al., 1995). The timing of lethality and
phenotype of both the Wnt and FGF4 signaling mutants is
similar to the lethality of Foxd3 null embryos, consistent
with the possibility that Foxd3 regulates these pathways in
vivo (Hanna et al., 2002). Finally, loss of Foxd3 in ESCs also
impacts expression of transcription factors as indicated by
enrichment of three functional categories: transcription
regulator activity, transcription factor complex, and posi-
tive regulation of transcription. Interestingly, as summa-
rized in Table 1, expression of some misregulated genes is
increased in the absence of Foxd3 (red) while expression of
others is decreased (blue) suggesting that Foxd3 both
activates and represses these biological processes. Our
findings also suggest that Foxd3 functions in stem cells by
primarily regulating development and differentiation.
Analysis of the results obtained from themicroarray allowed
us to prioritize the verification of changes in expression of
genes encoding proteins known to control stem cell properties
in addition to those with unknown function. Using qRT-PCR to
assay gene expression, we confirmed 10 genes of interest that
were significantly misregulated (p-value b 0.05) after 24 h of
TM treatment (Fig. 2B, purple). We also assayed gene
expression after 12 h of TM treatment, and unsurprisingly,
found that no genes of interest were misregulated (Fig. 2B,
green). Eight of the misregulated genes (Eras, Fosb, Clip2,
Smarcd3, Ngfr, Sox4, Tub, and Safb) were downregulated
while 2 (Pmaip1 and Sox15) were upregulated, suggesting that
Foxd3 both positively and negatively regulates expression of
putative target genes.Identification of direct targets of Foxd3
To determine whether the misregulated genes are direct
targets of Foxd3, we used rVista to identify putative Foxd3
binding sites less than 20 kb away from themisregulated genes,
and verified Foxd3 occupancy using chromatin immunoprecip-
itation (ChIP) assays followed by quantitative PCR (qPCR).
Using this assay, we determined that 6 of the 10 misregulated
genes (Sox4, Safb, Sox15, Fosb, Pmaip1 and Smarcd3) were
direct targets of Foxd3 (Fig. 2C, gray bars). Foxd3 occupancy at
the λpreB locus served as a positive control (Liber et al., 2010),
B0
0.5
1
1.5
2
2.5
12 Hours
24 Hours
R
el
at
iv
e 
m
R
N
A 
ex
pr
es
sio
n
**
** ***
* * *
*
*
*
C
0
1
2
3
4
5
6
7
8
NT
TM
R
el
at
iv
e 
en
ric
hm
en
t
**
*
* *
*
*
λ
*
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
Sox15 Sox4 Alb1
*
**
D
R
el
at
iv
e 
en
ric
hm
en
t
0
0.2
0.4
0.6
0.8
1
1.2
1.4
D0 D3 D5
NT
TM
R
el
at
iv
e 
So
x1
5 
m
R
N
A 
Ex
pr
es
sio
n 
**
E F
R
el
at
iv
e 
So
x4
 
m
R
N
A 
Ex
pr
es
sio
n 
0
1
2
3
4
5
6
7
D0 D3 D5
NT
TM
*
A
Figure 2 Identification of direct targets of Foxd3. A. Hierarchiacal clustering of 423 probes detected as significantly different (at
least 1.5-fold, p-value b 0.05) between NT and TM treated ESCs. Values shown are log2, and bright red, bright blue, and gray indicate
the highest, lowest, and median normalized signal values, respectively. Vertical dendrograms represent the individual samples, of
which there are three replicates for each sample type. B. qRT-PCR validation of misregulated genes identified using microarrays at 12
(green) and 24 (purple) hours post TM treatment. The red line indicates the relative gene expression levels in NT control ESCs. N = 4
experiments. C. qPCR following ChIP experiments was used to identify novel targets of Foxd3. The data are portrayed as enrichment
over a non-specific rabbit IgG antibody in untreated (NT, gray) and TM treated (green) ESCs after 24 h in culture. The λ5preB locus
serves as a positive control while the HPRT coding sequence serves as a negative control. N = 5 experiments. D. qPCR following ChIP
experiments to determine if Ser5-PolII occupancy is altered at the proximal promoters of Sox15 and Sox4 in the absence of Foxd3. The
data depict the enrichment of Ser5-PolII in induced mutant (TM) ESCs after 48 h in culture normalized to untreated cells (red line).
The enrichment at a sequence −7 kb from the Alb1 gene serves as a negative control; enrichment in both TM and untreated cells are
at least 3-fold less at this sequence than at Sox4 and Sox15 proximal promoters. E–F. qRT-PCR analysis of Sox15 (E) and Sox4 (F)
expression in untreated (control, gray) and TM treated (induced mutant, green) EBS at Day 0 (D0), Day 3 (D3), and Day 5 (D5)
normalized to expression in untreated ESCs at D0. N = 3 experiments. In all panels, error bars indicate SEM. *p b 0.05, **p b 0.01, and
***p b 0.001.
236 J.L. Plank et al.while the Hprt coding sequence served as a negative control.
To validate specificity of the antibody, we analyzed Foxd3
occupancy in TM treated ESCs and, as expected, did not detect
Foxd3 at any loci (Fig. 2C, green bars). Together, these results
indicate that the identified binding sites are novel targets of
Foxd3. The Foxd3 binding sites near Fosb, Safb, Smarcd3, andSox4 are conserved among mice, rats, and humans; however,
the antibody used for ChIP assays did not provide reproducible
results in hESCs (data not shown).
To further characterize the role of Foxd3 in regulating ES
cell properties, we chose to analyze developmental process-
es misregulated in the absence of Foxd3. Furthermore,
Table 1 Enriched functional categories in mutant cells.
Gene ontology category P value Genes
Biological process
Epithelium development 6.3 x 10–5
Fgf42, Cobl, Lama1, Vegfc, Sfrp1, Pou2f3, 
Tgm1, Car9, Sfn, Sprr2i
Tissue morphogenesis 8.8 x 10–4 Fgfr2, Cobl, Lama1, Vegfc, Sfrp1, Wnt3a, 
Car9, Ngfr*
Positive regulation of transcription 9.7 x 10–4 Zbtb7b, Hoxa1, Smarcd3*, Pou2f3, Ebf1, 
Pax8, Tead1, Sox4*, Sox15, Smarca1,Foxd3
Epithelial cell differentiation 1.2 x 10–3 Fgfr2, Lama1, Pou2f3, Tgm1, Sfn, Sprr2i
Embryonic organ development 4.7 x 10–3 Fgfr2, Hoxa1, Gcm1, Otx1*,Wnt3a, Ttpa, 
Foxd3
Morphogenesis of an epithelium 5.3 x 10–3 Fgfr2, Cobl, Lama1, Vegfc, Sfrp1, Car9
Embryonic morphogenesis 8.6 x 10–3
Fgfr2, Cobl, Hoxa1, Vegfc, Gcm1,Otx1*,
Wnt3a, Fgf4
Wnt receptor signaling pathway 1.0 x 10–2 Dact1, Sfrp1, Wnt3a, Sfrp4, Sox4*
Regulation of RNA metabolism 1.4 x 10–2
Calcr, Zbtb7b, Zfp345, Tcfap2c, Otx1*, 
Tead1, Sox4*, Fosb*, Obox6, Hoxa1, Gcm1,
Pou2f3, Ebf1, Pax8, Sox15, Zfp820, 
Smarca1, Foxd3
Morphogenesis of a branching 
structure
4.7 x 10–2 Fgfr2, Lama1, Gcm1, Sfrp1
Cellular component
Cell–cell junction 1.6 x 10–2 Tgm1, Scn2a1, Esam, Jam2, Calb2
Transcription factor complex 4.2 x 10–2 Gcm1, Pou2f3, Pax8, Tead1, Foxd3
Molecular function
Transcription regulator activity
3.5 x 10–3
Zbtb7b, Tcfap2c, Otx1*, Tead1, Sox4*, 
Fosb*, Obox6, Msc, Hoxa1, Gcm1, Olig3, 
Smarcd3*, Pou2f3, Pax8, Ebf1, Sox15, 
Smarca1, Foxd3
Signaling pathways
WNT signaling pathway 2.1 x 10–2
Dact1, Sfrp1, Smarcd3*, Wnt3a, Sfrp4, 
Prkch, Smarca1
FGF signaling pathway 5.6 x 10–2 Fgfr2, Prkch, Sfn, Fgf4
Functional classification of genes misregulated after 24 hours of TM treatment. The p-value was calculated by the online database and
functional analysis program, DAVID using Fisher’s Exact Test. Upregulated genes are indicated by red text while downregulated genes are
indicated by blue text.
⁎These genes fell below the cut-off criteria chosen for analysis of microarray data but were validated by qRT-PCR.
237Transcriptional targets of Foxd3 in murine ES cellspublished data demonstrates that Foxd3 and Sox2 interact in
ESCs and are replaced by Foxp1 and Sox4 in differentiating B
cells (Liber et al., 2010). Therefore, we focused our analyses
on the misregulated Sox family members, Sox15 and Sox4. We
detected Foxd3 bound at regions 4.8 kb upstream of the Sox15
transcriptional start site and 9.5 kb downstream of the Sox4
gene (Fig. 2C). To determine if Sox15 and Sox4 transcription is
altered in the absence of Foxd3, we used ChIP assays to analyze
the occupancy of RNA Polymerase II phosphorylated at Serine5(Ser5-PolII). There was a significant increase in Ser5-PolII
occupancy at the Sox15 proximal promoter in TM-treated cells
compared to controls. Alternatively, Ser5-PolII occupancy was
drastically decreased at the Sox4 promoter in ESCs lacking
Foxd3 (Fig. 2D). These data suggest that Foxd3 directly
regulates the transcription of these two target genes.
Additionally, using an embryoid body (EB) assay to
analyze gene expression in differentiating cells, we deter-
mined that Sox15 mRNA levels quickly decreased while Sox4
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Figure 3 Foxd3 functions upstream of genes required for
skeletal muscle development. A. qRT-PCR data demonstrating
the relative expression of Foxd3, Myf5, and Pax3mRNAs in Foxd3
induced mutant ESCs cultured for 24 (purple) and 48 (blue) hours.
Red line indicates expression of these mRNAs in untreated ESCs.
Error bars indicate SEM. *p b 0.05 and ***p b 0.001. B. Model of
Foxd3 and Sox15 in mESCs in the process of skeletal muscle
differentiation. In a control progenitor cell (left), Foxd3 represses
Sox15 allowing precise regulation of Pax3 and Myf5 and proper
skeletal muscle development. In the absence of Foxd3 (right),
Sox15 is upregulated, resulting in an increase in Pax3 and a
decrease in Myf5 expression.
238 J.L. Plank et al.mRNA levels gradually increased upon differentiation of
untreated ESCs (Figs. 2E–F, gray). Consistent with increased
Sox15 mRNA levels in ESCs lacking Foxd3, Sox15 mRNA is
maintained in EBs lacking Foxd3 (Fig. 2E, green), while Sox4
mRNA was decreased in TM-treated cells (Fig. 2F, green).
Together, these data indicate that Sox4 and Sox15 expres-
sion is altered in EBs lacking Foxd3.
Foxd3 functions upstream of genes required for
skeletal muscle development
While some data suggest that Foxd3 functions as a transcrip-
tional activator (Lee et al., 2006; Thomas & Erickson, 2009;
Pan et al., 2006), compelling evidence indicates that Foxd3
functions as a transcriptional repressor in mesoderm induc-
tion in Xenopus (Steiner et al., 2006; Yaklichkin et al., 2007).
Therefore, we focused our analyses on Sox15, which is
repressed by Foxd3. Because Sox15 is regulated by Foxd3,
and Sox15 is a critical regulator of skeletal muscle differen-
tiation in vitro (Beranger et al., 2000; Lee et al., 2004; Savage
et al., 2009), we sought to first characterize the effects of
loss of Foxd3 on genes functioning downstream of Sox15
required to regulate skeletal muscle development. Skeletal
muscle is derived from paraxial mesoderm and requires the
myogenic bHLH transcription factors MyoD and Myf5 for
differentiation (Rudnicki et al., 1993). Following determina-
tion to the skeletal muscle lineage, myoblast progenitor cells
divide, align, and fuse to generate multinucleated myotubes,
resulting in mature muscle fibers that also contain muscle
stem cells. A putative stem cell population, the satellite cells,
is capable of proliferating to generate new myoblasts that
fuse with mature muscle fibers (Kuang et al., 2007).
The transcription factors Pax3 and Sox15 function upstream
of Myf5 and MyoD (Beranger et al., 2000; Lee et al., 2004;
Savage et al., 2009). Sox15 null animals cannot regenerate
skeletalmuscle following injury, while overexpression of Sox15
results in increased Pax3 expression, decreased Myf5 expres-
sion, and an expansion of immature myoblasts (Savage et al.,
2009; Maruyama et al., 2005). Because Sox15 is upregulated in
Foxd3 induced mutant ESCs and Sox15 inhibits myogenesis, we
hypothesized that ESCs lacking Foxd3 cannot be directed to
produce mature skeletal muscle. Additionally, Foxd3 is
expressed in the paraxial mesoderm of mouse embryos,
further suggesting that Foxd3 may be an important regulator
of skeletal muscle development (Arduini & Brivanlou, 2012).
To determine if genes functioning downstream of Sox15 are
misregulated in the absence of Foxd3, we assayedmRNA levels
of thesemyogenic genes in differentiating ESCs using qRT-PCR.
Consistent with our hypothesis, Myf5 expression decreased
while Pax3 expression increased (Fig. 3A), suggesting that
Foxd3 functions upstream of Sox15 to regulate myogenesis.
Discussion
We identified several genes, pathways, and biological
functions that are misregulated in ESCs lacking Foxd3.
Additionally, we identified 6 novel targets of Foxd3: Sox4,
Safb, Sox15, Fosb, Pmaip1, and Smarcd3. We further
characterized the expression of genes that function down-
stream of Sox15, and we showed that Foxd3 directly or
indirectly regulates genes required for skeletal muscledevelopment and regeneration, uncovering a novel role for
Foxd3.
The data presented in Fig. 3, together with previous work
in the lab (Liu & Labosky, 2008), suggest that Foxd3 induced
mutant ESCs precociously express genes required for
mesoderm induction, but they are likely unable to differen-
tiate into skeletal muscle. These data are consistent with
the model shown in Fig. 3B in which Foxd3 represses Sox15
transcription resulting in increased Pax3 and decreased Myf5
expression in ESCs undergoing differentiation. An increase in
Pax3 in skeletal muscle progenitors may result in increased
self-renewal and decreased differentiation, limiting the
number of mature skeletal muscle fibers (Epstein et al.,
1995; Young & Wagers, 2010). Additionally, decreased Myf5
may result in decreased generation of skeletal muscle. The
data presented here are consistent with a recent publication
demonstrating the function of FOXD3 in hESCs; overexpres-
sion of FOXD3 in hESCs induces differentiation to paraxial
mesoderm, including differentiation into skeletal myoblasts
(Arduini & Brivanlou, 2012). Together, these data suggest a
conserved function for Foxd3 in regulating skeletal muscle
development in mammals.
239Transcriptional targets of Foxd3 in murine ES cellsWe hypothesize that the other targets of Foxd3 (Sox4,
Safb, Fosb, Pmaip1 and Smarcd3) also regulate ES cell
properties, and based on published accounts, several of these
targets are of future interest. The transcription factor Sox4 is
required for cardiac outflow tract development (Schilham et
al., 1996; Ya et al., 1998; Maschhoff et al., 2003), a process
regulated by the cardiac neural crest, another multipotent
progenitor population in which Foxd3 function is critical
(Mundell & Labosky, 2011; Teng et al., 2008; Nelms et al.,
2011). The transcription factor FBJ osteosarcoma oncogene B
(Fosb) promotes osteoblast differentiation while inhibiting
adipogenesis (Sabatakos et al., 2000) suggesting that inhibi-
tion of Fosb by Foxd3 regulates differentiation of these
lineages. Smarcd3 (also called Baf60c), a member of the Swi/
Snf chromatin remodeling complex, associates with MyoD to
promote transcription of genes required for myogenesis
(Forcales et al., 2012; Ochi et al., 2008). While Sox15, Sox4,
Fosb, and Smarcd3 have been implicated in regulating
differentiation of disparate lineages, no one has carefully
investigated the role of these proteins in maintaining ESC
properties, and it is possible that Sox4, Fosb, and Sox15 are
involved in maintaining pluripotency in ESCs.
In addition to genes regulating pluripotency, two novel
Foxd3 targets have the potential to regulate self-renewal of
ESCs. Smarcd3 is a component of a Swi/Snf complex and is
required to regulate self-renewal of neural stem cells (Lamba
et al., 2008). While Smarcd3 mRNA can be detected in ESCs
(Fig. 2B), to date, no one has analyzed the requirement for
this protein in regulating self-renewal of ESCs. In addition, the
function of the ubiquitously expressed nuclear scaffolding
protein, Safb, has yet to be determined. It has been suggested
that Safb may regulate the cell cycle, consistent with the
possibility that Safb is required for ES cell proliferation and/or
self-renewal (Huerta et al., 2007; Tapia et al., 2009; Debril et
al., 2005). Together, this evidence from the literature is
consistent with the hypothesis that these new targets of Foxd3
may regulate self-renewal in ESCs.
Lastly, some targets of Foxd3 are also required to prevent
aberrant apoptosis. Safb indirectly represses apoptotic genes
in breast cancer cells (Lee et al., 2007; Chan et al., 2007).
Therefore, decreased Safb expression in Foxd3 mutant ESCs
may lead to an increase in apoptosis. Finally, Pmaip1 (also
called Noxa) is a direct target of Foxd3 and is a critical
regulator of cell death. Pmaip1 is required for the activation
of caspases and contributes to p53-dependent apoptosis (Li
et al., 2006; Oda et al., 2000; Yakovlev et al., 2004).
Altogether, these data from our laboratory and others
suggest that Foxd3 functions upstream of critical regulators
of stem cell properties. Prior to this manuscript, only two
direct targets of Foxd3 were identified, and the work
reported here has uncovered several factors that function
downstream of Foxd3. Additional characterization of the
function of these factors in ESCs will further elucidate gene
regulatory networks controlling stem cell properties.
Supplementary data to this article can be found online at
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